Antibacterial treatment and composition
    2.
    发明授权
    Antibacterial treatment and composition 有权
    抗菌处理及组成

    公开(公告)号:US07341752B2

    公开(公告)日:2008-03-11

    申请号:US11215765

    申请日:2005-08-30

    CPC classification number: A61K36/28 A61K31/7048 Y02A50/478 A61K2300/00

    Abstract: A method for treating a bacterial infection in a subject by administration of an effective amount of centaurein alone or in combination with a bacteriocide. Also described is a composition containing an effective combined amount of centaurein and a bacteriocide useful for treating a bacterial infection in a subject.

    Abstract translation: 通过单独施用有效量的百吗百醇或与杀细菌剂组合来治疗受试者的细菌感染的方法。 还描述了含有有效组合量的百里灵素和可用于治疗受试者细菌感染的杀菌剂的组合物。

    BUTANOL EXTRACT OF BIDENS PILOSA
    4.
    发明申请
    BUTANOL EXTRACT OF BIDENS PILOSA 有权
    BUTANOL提取物BIDENS PILOSA

    公开(公告)号:US20090062216A1

    公开(公告)日:2009-03-05

    申请号:US12263896

    申请日:2008-11-03

    CPC classification number: A61K36/28 C07H15/10

    Abstract: A method of treating a Th1-mediated disorder includes administering to a subject in need of the treatment an effective amount of a compound of the formula I: wherein R1 is H, alkyl, aryl, or cyclyl; R2 is pyranose; R3 is H or alkyl; m is 2, 3, 4, 5, or 6; n is 0, 1, 2, or 3; o is 0, 1, 2, 3, 4; p is 1, 2, 3, or 4; and the Th1-mediated disorder is non-obese diabetes, Crohn's colitis, autoimmune hemolytic anemia, rheumatoid arthritis, autoimmune encephalitis, multiple sclerosis, or autoimmune myocarditis. Also disclosed is a pharmaceutical composition including a compound of formula I above and a pharmaceutically acceptable carrier.

    Abstract translation: 治疗Th1介导的病症的方法包括向需要治疗的受试者施用有效量的式I化合物:其中R 1是H,烷基,芳基或环基; R2是吡喃糖; R3是H或烷基; m为2,3,4,5或6; n为0,1,2或3; o是0,1,2,3,4; p是1,2,3或4; 并且Th1介导的病症是非肥胖性糖尿病,克罗恩病的结肠炎,自身免疫性溶血性贫血,类风湿性关节炎,自身免疫性脑炎,多发性硬化或自身免疫性心肌炎。 还公开了包含上述式I化合物和药学上可接受的载体的药物组合物。

    Antibacterial treatment and composition
    5.
    发明申请
    Antibacterial treatment and composition 有权
    抗菌处理及组成

    公开(公告)号:US20070048395A1

    公开(公告)日:2007-03-01

    申请号:US11215765

    申请日:2005-08-30

    CPC classification number: A61K36/28 A61K31/7048 Y02A50/478 A61K2300/00

    Abstract: A method for treating a bacterial infection in a subject by administration of an effective amount of centaurein alone or in combination with a bacteriocide. Also described is a composition containing an effective combined amount of centaurein and a bacteriocide useful for treating a bacterial infection in a subject.

    Abstract translation: 通过单独施用有效量的百吗百醇或与杀细菌剂组合来治疗受试者的细菌感染的方法。 还描述了含有有效组合量的百里灵素和可用于治疗受试者细菌感染的杀菌剂的组合物。

    Butanol extract of Bidens pilosa
    6.
    发明授权
    Butanol extract of Bidens pilosa 有权
    丁香的丁醇提取物

    公开(公告)号:US08048860B2

    公开(公告)日:2011-11-01

    申请号:US12263896

    申请日:2008-11-03

    CPC classification number: A61K36/28 C07H15/10

    Abstract: A method of treating a Th1-mediated disorder includes administering to a subject in need of the treatment an effective amount of a compound of the formula I: wherein R1 is H, alkyl, aryl, or cyclyl; R2 is pyranose; R3 is H or alkyl; m is 2, 3, 4, 5, or 6; n is 0, 1, 2, or 3; o is 0, 1, 2, 3, 4; p is 1, 2, 3, or 4; and the Th1-mediated disorder is non-obese diabetes, Crohn's colitis, autoimmune hemolytic anemia, rheumatoid arthritis, autoimmune encephalitis, multiple sclerosis, or autoimmune myocarditis. Also disclosed is a pharmaceutical composition including a compound of formula I above and a pharmaceutically acceptable carrier.

    Abstract translation: 治疗Th1介导的病症的方法包括向需要治疗的受试者施用有效量的式I化合物:其中R 1是H,烷基,芳基或环基; R2是吡喃糖; R3是H或烷基; m为2,3,4,5或6; n为0,1,2或3; o是0,1,2,3,4; p是1,2,3或4; 并且Th1介导的病症是非肥胖性糖尿病,克罗恩病的结肠炎,自身免疫性溶血性贫血,类风湿性关节炎,自身免疫性脑炎,多发性硬化或自身免疫性心肌炎。 还公开了包含上述式I化合物和药学上可接受的载体的药物组合物。

Patent Agency Ranking